Short answer
ORTHOPEDIATRICS CORP (KIDS) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 earnings release announced for quarter ended June 30, 2026.
ORTHOPEDIATRICS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 earnings release announced for quarter ended June 30, 2026
- Unaudited condensed consolidated financial statements and supporting financial data available in Exhibit 99.1
- Investor focus: quarterly revenue, profitability, cash flow, and guidance details in the accompanying release
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $70.5M, up 15%, with Trauma and Deformity growth 26% offsetting Scoliosis decline of 9%
- Adjusted EBITDA rose to $6.8M from $4.1M, while gross margin expanded to 74% from 72%
- Free cash flow use improved 78% to $3.1M, supporting management’s target for full-year 2026 cash-flow breakeven
- 2026 revenue guidance increased to $265.0M-$269.0M, with adjusted EBITDA guidance approximately $25.0M
- Liquidity declined to $47.9M from $62.9M at December 31, 2025, while Q2 net loss remained $7.2M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ORTHOPEDIATRICS CORP 8-K filings
Get the next KIDS 8-K as it lands
Follow KIDS for push alerts, or ask the research agent what this filing means.